U.S. Markets closed

Lineage Cell: 3Q Earnings Snapshot

ALAMEDA, Calif. (AP) _ Lineage Cell Therapeutics, Inc. (LCTX) on Tuesday reported a third-quarter loss of $16.5 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Alameda, California-based company said it had a loss of 11 cents. Losses, adjusted for non-recurring costs, were 4 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 5 cents per share.

The biotechnology company posted revenue of $567,000 in the period, which fell short of Street forecasts. Three analysts surveyed by Zacks expected $940,000.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LCTX at https://www.zacks.com/ap/LCTX